Cargando…

Response to chemotherapy combined with anlotinib plus anlotinib maintenance in intra-abdominal desmoplastic small round cell tumors (IADSRCT): a case report and literature review

BACKGROUND: Intra-abdominal desmoplastic small round cell tumors (IADSRCT) are rare and aggressive neoplasia that are resistant to chemotherapy. Anlotinib is an oral multi-target tyrosine kinase inhibitor that also has anti-angiogenic and anti-proliferative properties. In this article, we report on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cheng, Ke, Liu, Xia, Chen, Ye, Zhou, Kexun, Li, ZhiPing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9386944/ https://www.ncbi.nlm.nih.gov/pubmed/35978277 http://dx.doi.org/10.1186/s12876-022-02463-y

Ejemplares similares

Use of anlotinib in intra-abdominal desmoplastic small round cell tumors: a case report and literature review
por: Chen, Hui-Min, et al.
Publicado: (2018)

Safety and Efficacy of Chemotherapy Combined with Anlotinib Plus Anlotinib Maintenance in Chinese Patients with Advanced/Metastatic Soft Tissue Sarcoma
por: Wang, Hai-ying, et al.
Publicado: (2020)

Efficacy and Safety of Anlotinib Combined with Liposomal Doxorubicin Followed by Anlotinib Maintenance in Metastatic Soft Tissue Sarcomas
por: Liu, Zhiyong, et al.
Publicado: (2021)

Intra-abdominal desmoplastic small round cell tumor.
por: Nathan, J. D., et al.
Publicado: (2001)

Intra-abdominal desmoplastic small round cell tumor.
por: Nathan, J. D., et al.
Publicado: (1999)

Intra-abdominal desmoplastic small round cell tumor
por: Thandassery, Ragesh Babu, et al.
Publicado: (2014)

Intra-abdominal desmoplastic small round cell tumor: Presentation of four cases and review of the literature
por: Biswal, Biswa Mohan, et al.
Publicado: (2010)

Multi-Omics Analysis of Anlotinib in Pancreatic Cancer and Development of an Anlotinib-Related Prognostic Signature
por: Zhang, Xi, et al.
Publicado: (2021)

Intra-Abdominal Desmoplastic Small Round Cell Tumor: Current Treatment Options and Perspectives
por: Wei, Guixia, et al.
Publicado: (2021)

Hypertensive Retinopathy Secondary to Anlotinib Treatment
por: Zhang, Xiaohua, et al.
Publicado: (2020)

Pembrolizumab Plus Chemotherapy or Anlotinib vs. Pembrolizumab Alone in Patients With Previously Treated EGFR-Mutant NSCLC
por: Chen, Ya, et al.
Publicado: (2021)

Efficacy and safety of anlotinib plus programmed death-1 blockade versus anlotinib monotherapy as second or further-line treatment in advanced esophageal squamous cell carcinoma: A retrospective study
por: Liu, Ying, et al.
Publicado: (2022)

Combination of Anlotinib and Celecoxib for the Treatment of Abdominal Desmoid Tumor: A Case Report and Literature Review
por: Wang, Jianzheng, et al.
Publicado: (2022)

Safety and efficacy of ICI plus anlotinib vs. anlotinib alone as third-line treatment in extensive-stage small cell lung cancer: a retrospective study
por: Chen, Qing, et al.
Publicado: (2021)

Intra-abdominal desmoplastic small blue round cell tumor: A case report
por: Taei, Tareq Hamed Al, et al.
Publicado: (2022)

Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review
por: Reijers, Sophie J. M., et al.
Publicado: (2023)

Antitumor effects of anlotinib in thyroid cancer
por: Ruan, Xianhui, et al.
Publicado: (2018)

Malignant mediastinal mesothelioma treated with anlotinib: a case report and review of the literature
por: Zhang, Yishi, et al.
Publicado: (2023)

Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
por: Li, Jia, et al.
Publicado: (2022)

Gemcitabine Plus Anlotinib Is Effective and Safe Compared to Gemcitabine Plus Docetaxel in Advanced Soft Tissue Sarcoma
por: Liu, Zhiyong, et al.
Publicado: (2022)

Application of neoadjuvant chemotherapy combined with anlotinib in occult breast cancer: A case report and review of literature
por: Zhang, Yu, et al.
Publicado: (2021)

Anlotinib combined with chemotherapy and immunotherapy for advanced pulmonary sarcomatoid cancer: a case report and literature review
por: Piao, Mei-Na, et al.
Publicado: (2022)

Bronchial Fistula: Rare Complication of Treatment with Anlotinib
por: DENG, Pengbo, et al.
Publicado: (2020)

Anlotinib plus camrelizumab achieved long‐term survival in a patient with metastatic esophageal neuroendocrine carcinoma
por: Zhou, Lingxiao, et al.
Publicado: (2023)

Removal of an intra-abdominal desmoplastic small round cell tumor by repetitive debulking surgery: A case report and literature review
por: SHIMAZAKI, JIRO, et al.
Publicado: (2014)

Intra‐abdominal omental mass as a desmoplastic round cell tumor: A rare case report
por: Bohara, Sujan, et al.
Publicado: (2023)

Anlotinib-induced acute myocardial infarction: A case report and literature review
por: Liu, Guihong, et al.
Publicado: (2020)

The efficacy and safety of anlotinib treatment for advanced lung cancer
por: Shao, Lan, et al.
Publicado: (2019)

Anlotinib Downregulates RGC32 Which Provoked by Bevacizumab
por: Liu, Zhujun, et al.
Publicado: (2022)

Intra-abdominal desmoplastic small round cell tumors: CT and FDG-PET/CT findings with histopathological association
por: CHEN, JINGJING, et al.
Publicado: (2016)

A Trial of the Safety and Efficacy of Chemotherapy Plus Anlotinib vs Chemotherapy Alone as Second- or Third-Line Salvage Treatment for Advanced Non-Small Cell Lung Cancer
por: Wang, Hai-ying, et al.
Publicado: (2020)

Partial Response After Toripalimab Plus Anlotinib for Advanced Metaplastic Breast Carcinoma: A Case Report
por: Fu, Yang, et al.
Publicado: (2022)

Salvage therapy of osimertinib plus anlotinib in advanced lung adenocarcinoma with leptomeningeal metastasis: A case report
por: Wu, Kai, et al.
Publicado: (2022)

Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review
por: Li, Jing, et al.
Publicado: (2021)

PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study
por: Du, Xin-Xing, et al.
Publicado: (2022)

Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
por: Hu, Nanlin, et al.
Publicado: (2021)

Application of Anlotinib Combined With Neoadjuvant Chemotherapy in Primary EWS/PNET of Lung: A Case Report
por: Fan, YH, et al.
Publicado: (2022)

The Combination of Anlotinib and Gemcitabine/Docetaxel in Patients with Metastatic Osteosarcoma Who Have Failed Standard Chemotherapy
por: Wang, Tian, et al.
Publicado: (2022)

Targeted therapy with anlotinib for patient with recurrent glioblastoma: A case report and literature review
por: Lv, Yajuan, et al.
Publicado: (2019)

Posterior Reversible Encephalopathy Syndrome Associated With Anlotinib: A Case Report and Literature Review
por: Nan, Di, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_kifi3bg9nbk22m6msh6onki8ug